TITLE

Early hepatitis C RNA testing is most cost effective strategy

PUB. DATE
February 2009
SOURCE
Nursing Standard;2/18/2009, Vol. 23 Issue 24, p16
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that researchers in France have found that a strategy based on early hepatitis C RNA testing shortens the time healthcare workers exposed to the hepatitis C virus must wait for the results of their virus status, is reasonably cost effective, and results in a lower risk of progression to chronic hepatitis C.
ACCESSION #
36935775

 

Related Articles

  • Broadened HCV screening recommended.  // PharmacoEconomics & Outcomes News;3/31/2012, Issue 650, p7 

    The article reports on a study which found that broadened screening of the whole U.S. population for hepatitis C virus (HCV) would be cost effective compared with the current practice of screening only high-risk individuals.

  • Hepatitis C screening -- cost effective in MSM in the US?  // PharmacoEconomics & Outcomes News;4/28/2012, Issue 652, p5 

    The article discusses research on the cost effectiveness of hepatitis C screening in HIV-infected men who have sex with men (MSM), referencing a study by B. P. Linas and colleagues published on the April 4, 2012 issue of "Clinical Infectious Diseases."

  • Routine antenatal screening for hepatitis C cost effective.  // PharmacoEconomics & Outcomes News;Jun2015, Vol. 729 Issue 1, p26 

    The article discusses research on the cost effectiveness of routine antenatal screening for hepatitis C, referencing a study by N. Selvapatt et al and published in the May 27, 2015 issue of the "Journal of Hepatology."

  • Identifying cost-effective strategies for hepatitis C testing.  // PharmacoEconomics & Outcomes News;Jul2015, Vol. 732 Issue 1, p21 

    The article reports on the cost effective strategies for testing current hepatitis C virus (HCV) infection through the antibody to HCV (HCVAb) in venipuncture blood, and quantitative nucleic acid test (NAT) for HCV RNA with similar viraemia sensitivity.

  • Spontaneous clearance of hepatitis C virus during pregnancy. Clohessy, Penelope; Polis, Suzanne; Post, Jeffrey // Obstetric Medicine (1753-495X);Mar2013, Vol. 6 Issue 1, p28 

    Spontaneous clearance of hepatitis C virus (HCV) is expected to be unlikely in pregnancy due to the relative immunosuppression and increase in viraemia that occurs. We report the first case of spontaneous clearance of hepatitis C virus (HCV) occurring in pregnancy.

  • HCV Screening to Enable Early Treatment of Hepatitis C: A Mathematical Model to Analyse Costs and Outcomes in Two Populations. Tramarin, A.; Gennaro, N.; Compostella, F. A.; Gallo, C.; Bonga, L. J. Wendelaar; Postma, M. J. // Current Pharmaceutical Design;Jun2008, Vol. 14 Issue 17, p1655 

    Early treatment of acute hepatitis C virus (HCV) infections reflects a new clinical paradigm and a significant option to reduce the socioeconomic burden of HCV. Therefore, this approach seems suitable as a new strategy to face HCV and prevent end stage liver diseases and premature deaths due to...

  • The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy. Mesquita, Fabio; Santos, Melina Erica; Benzaken, Adele; Corrêa, Renato Girade; Cattapan, Elisa; Sereno, Leandro Soares; Moscoso Naveira, Marcelo Contardo // BMC Public Health;11/2/2016, Vol. 16 Issue 1, p1 

    Background: Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications. In...

  • Hepatitis C: The silent killer of infected patients and... Petersen, Carolyn // Managed Healthcare;Jul98, Vol. 8 Issue 7, p45 

    Provides information on hepatitis C virus (HCV) which is the third infectious disease. How hepatitis C is transmitted; Reason relatively few people in the United States are aware of HCV; Eight groups which should be tested based on the epidemiology of the virus; How HCV can be treated. INSET:...

  • Transfusions to tattoos--the danger of hepatitis C. Albrecht, Jeffrey H.; Jensen, Donald M. // Patient Care;7/15/1996, Vol. 30 Issue 12, p112 

    Presents recommendations for physicians on screening their patients for hepatitis C infection. Clinical characteristics; Genetical information on the hepatitis C virus (HCV); People most at risk; Transaminase findings; Antibody testing; Use of RNA testing in research settings; Use of biopsy in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics